Agios Pharmaceuticals (AGIO) Change in Cash (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Change in Cash of $24.5 million for Q1 2026, up 783.52% on a QoQ basis from -$3.6 million in Q4 2025, and up 800.63% year-over-year from $2.7 million in Q1 2025.
Agios Pharmaceuticals (AGIO) Change in Cash (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' Change in Cash history runs 15 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- Quarterly Change in Cash rose 800.63% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.6 million (up 187.03% YoY) and the FY2025 annual result came in at $12.9 million, up 207.74% from the prior year.
- Change in Cash was $24.5 million for Q1 2026 at Agios Pharmaceuticals, up from -$3.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $169.2 million in Q3 2024 and bottomed at -$177.5 million in Q4 2024.
- A 5-year average of -$5.3 million and a median of $2.7 million in 2025 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 928.66% in 2024, while the deepest fall reached 843.48% in 2024.
- Agios Pharmaceuticals' Change in Cash stood at $16.8 million in 2022, then soared by 42.01% to $23.9 million in 2023, then tumbled by 843.48% to -$177.5 million in 2024, then surged by 97.98% to -$3.6 million in 2025, then soared by 783.52% to $24.5 million in 2026.
- Business Quant data shows AGIO's Change in Cash at $24.5 million in Q1 2026, -$3.6 million in Q4 2025, and $11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 24.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.47 Mn |
| Dec 31, 2025 | -3.58 Mn |
| Sep 30, 2025 | 11.84 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | -177.48 Mn |
| Sep 30, 2024 | 169.21 Mn |
| Jun 30, 2024 | -34.25 Mn |
| Mar 31, 2024 | 30.56 Mn |
| Dec 31, 2023 | 23.87 Mn |
| Sep 30, 2023 | -20.42 Mn |
| Jun 30, 2023 | -19.39 Mn |
| Mar 31, 2023 | -35.12 Mn |
| Dec 31, 2022 | 16.81 Mn |
| Sep 30, 2022 | 33.91 Mn |
| Jun 30, 2022 | 8.52 Mn |
| Mar 31, 2022 | -123.10 Mn |
| Dec 31, 2021 | -197.10 Mn |
| Sep 30, 2021 | -568.90 Mn |
| Jun 30, 2021 | -918.90 Mn |